There are formulations created to reduce the possibility of drug abuse and misuse, making it difficult to administer it in conditions other than those approved.
With the large amount of information found on the internet, it is often difficult for us to differentiate truth from myth or lie. That is why in this article we collect some claims of transdermal patches and if they are true or false.
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market.
The abuse and misuse of antibiotics in animals and humans are contributing to the increased threat posed by antimicrobial resistance.
What makes it possible for Amarin, a small player, to compete in the big leagues of the transdermal market? Here are the reasons in the voice of our Director & CEO, Sergio Lucero.
A review of the evolution of the transdermal market in the voice of Dr. Francisco Stefano, our director. Challenges of science and passion as protagonists.
We offer expertise and experience, together with flexibility and the ability to adapt to your needs.